These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 23404300)

  • 61. Comparison between sensor-augmented insulin therapy with continuous subcutaneous insulin infusion or multiple daily injections in everyday life: 3-day analysis of glucose patterns and sensor accuracy in children.
    Zucchini S; Scipione M; Balsamo C; Maltoni G; Rollo A; Molinari E; Mangoni L; Cicognani A
    Diabetes Technol Ther; 2011 Dec; 13(12):1187-93. PubMed ID: 21854193
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Automatic learning algorithm for the MD-logic artificial pancreas system.
    Miller S; Nimri R; Atlas E; Grunberg EA; Phillip M
    Diabetes Technol Ther; 2011 Oct; 13(10):983-90. PubMed ID: 21774690
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Basal rates and circadian profiles in continuous subcutaneous insulin infusion (CSII) differ for preschool children, prepubertal children, adolescents and young adults.
    Bachran R; Beyer P; Klinkert C; Heidtmann B; Rosenbauer J; Holl RW; ; ;
    Pediatr Diabetes; 2012 Feb; 13(1):1-5. PubMed ID: 21545675
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Automated overnight closed-loop glucose control in young children with type 1 diabetes.
    Elleri D; Allen JM; Nodale M; Wilinska ME; Mangat JS; Larsen AM; Acerini CL; Dunger DB; Hovorka R
    Diabetes Technol Ther; 2011 Apr; 13(4):419-24. PubMed ID: 21355719
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The SWITCH study (sensing with insulin pump therapy to control HbA(1c)): design and methods of a randomized controlled crossover trial on sensor-augmented insulin pump efficacy in type 1 diabetes suboptimally controlled with pump therapy.
    Conget I; Battelino T; Giménez M; Gough H; Castañeda J; Bolinder J;
    Diabetes Technol Ther; 2011 Jan; 13(1):49-54. PubMed ID: 21175271
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Proposed clinical application for tuning fuzzy logic controller of artificial pancreas utilizing a personalization factor.
    Mauseth R; Wang Y; Dassau E; Kircher R; Matheson D; Zisser H; Jovanovic L; Doyle FJ
    J Diabetes Sci Technol; 2010 Jul; 4(4):913-22. PubMed ID: 20663457
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes.
    Bergenstal RM; Tamborlane WV; Ahmann A; Buse JB; Dailey G; Davis SN; Joyce C; Peoples T; Perkins BA; Welsh JB; Willi SM; Wood MA;
    N Engl J Med; 2010 Jul; 363(4):311-20. PubMed ID: 20587585
    [TBL] [Abstract][Full Text] [Related]  

  • 68. STAR 3 randomized controlled trial to compare sensor-augmented insulin pump therapy with multiple daily injections in the treatment of type 1 diabetes: research design, methods, and baseline characteristics of enrolled subjects.
    Davis SN; Horton ES; Battelino T; Rubin RR; Schulman KA; Tamborlane WV
    Diabetes Technol Ther; 2010 Apr; 12(4):249-55. PubMed ID: 20210562
    [TBL] [Abstract][Full Text] [Related]  

  • 69. MD-logic artificial pancreas system: a pilot study in adults with type 1 diabetes.
    Atlas E; Nimri R; Miller S; Grunberg EA; Phillip M
    Diabetes Care; 2010 May; 33(5):1072-6. PubMed ID: 20150292
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
    Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
    Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Age-specific characteristics of the basal insulin-rate for pediatric patients on CSII.
    Klinkert C; Bachran R; Heidtmann B; Grabert M; Holl RW;
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):118-22. PubMed ID: 17973210
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Ontogenetic development of the human sleep-dream cycle.
    Roffwarg HP; Muzio JN; Dement WC
    Science; 1966 Apr; 152(3722):604-19. PubMed ID: 17779492
    [No Abstract]   [Full Text] [Related]  

  • 73. Classification of distinct baseline insulin infusion patterns in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion therapy.
    Holterhus PM; Odendahl R; Oesingmann S; Lepler R; Wagner V; Hiort O; Holl R; ;
    Diabetes Care; 2007 Mar; 30(3):568-73. PubMed ID: 17327322
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A cross-sectional international survey of continuous subcutaneous insulin infusion in 377 children and adolescents with type 1 diabetes mellitus from 10 countries.
    Danne T; Battelino T; Kordonouri O; Hanas R; Klinkert C; Ludvigsson J; Barrio R; Aebi C; Gschwend S; Mullis PE; Schumacher U; Zumsteg U; Morandi A; Rabbone I; Cherubini V; Toni S; de Beaufort C; Hindmarsh P; Sumner A; van Waarde WM; van den Berg N; Phillip M
    Pediatr Diabetes; 2005 Dec; 6(4):193-8. PubMed ID: 16390387
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report.
    Weinzimer SA; Ahern JH; Doyle EA; Vincent MR; Dziura J; Steffen AT; Tamborlane WV
    Pediatrics; 2004 Dec; 114(6):1601-5. PubMed ID: 15574621
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A framework for diabetes documentation and quality management in Germany: 10 years of experience with DPV.
    Grabert M; Schweiggert F; Holl RW
    Comput Methods Programs Biomed; 2002 Aug; 69(2):115-21. PubMed ID: 12100791
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Reference values for IGF-I throughout childhood and adolescence: a model that accounts simultaneously for the effect of gender, age, and puberty.
    Löfqvist C; Andersson E; Gelander L; Rosberg S; Blum WF; Albertsson Wikland K
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5870-6. PubMed ID: 11739455
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Sleep disorders.
    Howard BJ; Wong J
    Pediatr Rev; 2001 Oct; 22(10):327-42. PubMed ID: 11581486
    [No Abstract]   [Full Text] [Related]  

  • 79. Effects of sleep and sleep deprivation on interleukin-6, growth hormone, cortisol, and melatonin levels in humans.
    Redwine L; Hauger RL; Gillin JC; Irwin M
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3597-603. PubMed ID: 11061508
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Ultradian and circadian rhythms of sleep-wake and food-intake behavior during early infancy.
    Löhr B; Siegmund R
    Chronobiol Int; 1999 Mar; 16(2):129-48. PubMed ID: 10219486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.